The drug is taken once a day and there was a higher rate of tumors compared to placebos during trials.  BD 

U.S. drug regulators approved Astellas Pharma Inc's pill imagefor overactive bladder on Thursday, boosting the Japanese drugmaker's foothold in the market for the condition.  Mirabegron, the first drug in its class, works by activating a protein receptor in bladder muscles that relaxes them and helps the bladder fill and store urine. The pill is already approved in Japan.


Post a Comment